Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma. Read more about Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma.
Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines. Read more about Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines.
The economic burden of gynecologic cancers in California, 1998. Read more about The economic burden of gynecologic cancers in California, 1998.
Specific keynote: genome copy number abnormalities in ovarian cancer. Read more about Specific keynote: genome copy number abnormalities in ovarian cancer.
Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients. Read more about Phase II trial of gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed ovarian cancer patients.
Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC). Read more about Missed opportunities for cervical cancer screening of HMO members developing invasive cervical cancer (ICC).
Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma. Read more about Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinoma.
